Exhibit 99.1

================================================================================
                                FONAR CORPORATION

Fonar  MRI news @ aol . com                                The Inventor  of  MRI
For    Immediate    Release                                An  ISO  9001 Company

Contact:    Daniel  Culver,                                110   Marcus    Drive
Director of  Communications                                Melville, N.Y.  11747
Web site:     www.fonar.com                                Tel:  (631)  694-2929
Email: invest2007@fonar.com                                Fax:  (631)  390-1709
================================================================================

          FONAR Announces Fiscal 2007 Second Quarter Financial Results

MELVILLE,  NEW YORK,  February 9, 2006 - FONAR  Corporation  (NASDAQ-FONR),  The
Inventor of MR  Scanning(TM),  today  announced  its  financial  results for the
second quarter of fiscal 2007, which ended December 31, 2006.

Revenue  for the second  quarter for fiscal  2007 was $7.7  million  compared to
$10.5  million for the  corresponding  period of fiscal 2006.  During the second
fiscal 2007 quarter,  product sale  revenues were $2.1 million,  a decrease from
$4.2 million one year earlier.  The lower level of revenue is  attributable to a
slow  down  in  capital  equipment   purchases  by  customers  following  robust
UPRIGHT(TM)  Multi-Position(TM)  MRI sales in 2003, 2004 and 2005.  Sales of the
FONAR UPRIGHT(TM)  Multi-Position(TM)  MRI were negatively affected primarily by
marketing and advertising  pressure from our competitors.  These competitors are
motivated  to  minimize  the  unique   medical   benefits  of  the   UPRIGHT(TM)
Multi-Position(TM) MRI because they are prohibited from making a similar product
because of FONAR's patents protecting its product from infringement.

Service and repair  revenues for the second fiscal 2007 quarter  increased  from
$2.1 million to $2.4 million or by 16% in the fiscal second quarter of 2007 from
the same quarter of fiscal 2006.  In addition,  for the six month period  ending
December  31, 2006  service and repair fees  increased to $5.0 million from $4.0
million for the corresponding period of fiscal 2006. This 23% increase is due to
the  result  and  initiation  of  service   contract   agreements   from  recent
installations of FONAR UPRIGHT (TM)  Multi-Position(TM)  MRI units.  During this
six month period,  costs related to service and repair fees  decreased from $2.8
million to $2.5  million,  and  subsequently,  the gross  margin on service  and
repair fees increased  from 31% to 49%. As of December 31, 2006,  there were 115
FONAR UPRIGHT(TM) Multi-Position(TM) MRI units installed worldwide.

Net loss for the second  quarter of fiscal 2007 was $(5.5)  million,  or $(0.05)
loss per common share (basic and  diluted),  as compared to a net loss of $(5.4)
million,  or  $(0.05)  loss  per  common  share  (basic  and  diluted),  for the
corresponding period of fiscal 2006.

At December 31, 2006,  total cash and marketable  securities were  approximately
$8.7  million.  This  represented  an overall  decrease of  approximately  9% or
$800,000 as compared to the period  ending June 30, 2006 of  approximately  $9.5
million.  This,  however,  compares to a decrease of only $64,000 as compared to
September 30, 2006 which was approximately $8.7 million.

On December 31, 2006, total assets were $53.2 million, total current assets were
$34.5 million, total current liabilities were $28.4 million, and total long-term
liabilities were $1.4 million.

Commenting on the financial results for the second fiscal 2007 quarter,  Raymond
Damadian,  M.D.,  president  and chairman of FONAR,  said,  "A very  competitive
atmosphere  has led to a decline  in sales.  Subsequently,  we are  planning  to
expand our sales force, both in terms of hiring more sales personnel and further
establishment of a domestic network of distributors. The advantages of the FONAR
UPRIGHT(TM) Multi-Position(TM) MRI scanner are significant over our competitors'
recumbent-only,   single-position-only,  static  MRI  systems,  especially  when
imaging the spine. This is significant because spine MRI scans are approximately
half of all MRI scans done.  There were about 13 million spine scans done in the
U.S. last year and given the unique  advantages,  they should all be done by the
FONAR UPRIGHT(TM) Multi- Position(TM) MRI."

"We are encouraged by our recent sales," said Dr. Damadian.  "Recently FONAR and
GE Healthcare,  a manufacturer's  representative  for FONAR, sold an UPRIGHT(TM)
Multi-Position(TM)   MRI  to  the  Center  for  Diagnostic   Imaging  (CDI),  of
Minneapolis,  Minnesota. This is an important sale for FONAR because CDI is very
prestigious  in the MRI  market  place.  Last year,  readers of Medical  Imaging
Magazine,   a  leading,   national  diagnostic  imaging  industry   publication,
overwhelmingly  selected CDI as the "NUMBER ONE  FREESTANDING  IMAGING GROUP" in
the United States.  In addition,  several CDI  associates and a CDI  radiologist
were also  recognized  in the top ten in their  individual  categories."  Visit:
www.medicalimagingmag.com/issues/articles/2006-01_01.asp#freeimage

                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                          For the Three Months         For the Six Months
                           Ended December 31,           Ended December 31,
                           2006          2005           2006          2005
                       ------------  ------------   ------------  ------------
Revenues               $ 7,672,000   $ 10,541,000   $ 15,455,000  $ 20,694,000
Net Loss               $(5,470,000)  $ (5,358,000)  $(11,575,000) $(13,675,000)
Basic & Diluted Loss
per Common Share          $(0.05)         $(0.05)      $(0.10)        $(0.13)

About FONAR

FONAR{R}  was  incorporated  in  1978,  making  it the  first,  oldest  and most
experienced MRI manufacturer in the industry. FONAR introduced the world's first
commercial MRI in 1980, and went public in 1981. Since its inception,  FONAR has
installed  hundreds  of MRI  scanners  worldwide.  Their  stellar  product  line
includes  the FONAR  UPRIGHT(TM)  Multi-  Position(TM)  MRI  (also  known as the
UPRIGHT(TM) MRI and the STAND-UP(TM) MRI), the only whole-body MRI that performs
Multi-   Position(TM)   Imaging  (mpMRI(TM))  and  scans  patients  in  numerous
weight-bearing positions,  i.e. standing,  sitting, in flexion and extension, as
well   as  the   conventional   lie-down   position.   The   FONAR   UPRIGHT(TM)
Multi-Position(TM)  MRI often sees the  patient's  problem  that other  scanners
cannot because they are single  position,  lie-down only.  With one half million
patients scanned, the patient-friendly FONAR UPRIGHT(TM) Multi- Position(TM) MRI
has a near zero claustrophobic  rejection rate by patients.  A radiologist said,
"FONAR  UPRIGHT(TM)  MRI - No More  Claustrophobia  - The  Tunnel  Is  Gone." As
another  FONAR  customer  states,  "If the  patient  is  claustrophobic  in this
scanner,  they'll be  claustrophobic  in my parking lot."  Approximately  85% of
patients  are scanned  sitting  while they watch a 42" flat  screen TV.  FONAR's
latest  MRI  scanner  is the FONAR  360,  a  room-size  recumbent  scanner  that
optimizes openness while facilitating  physician access to the patient. FONAR is
headquartered on Long Island, New York, and has approximately 400 employees.

                                      ###

The Inventor of MR  Scanning(TM),  STAND-UP(TM)  MRI, True  Flow(TM) MRI,  FONAR
UPRIGHT(TM)  MRI,  Position(TM)  MRI, Full Range of Motion,  The Proof is in the
Picture(TM), and PMRI(TM) are trademarks of FONAR.

                  Be sure to visit FONAR's Web site for Company
                        product and investor information:
                                  www.fonar.com
________________________________________________________________________________

This release may include forward-looking statements from the company that may or
may not materialize.  Additional  information on factors that could  potentially
affect the company's  financial results may be found in the company filings with
the Securities and Exchange Commission.

                                       ###